Vicapsys Life Sciences Inc (CE) (VICP) Actualités

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14C - Other definitive information statements

Form PRE 14C - Other preliminary information statements

Form D - Notice of Exempt Offering of Securities

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

Amended Current Report Filing (8-k/a)

0001468639 true Amendment No.1 0001468639 2023-05-12 2023-05-12 iso4217:USD...

Quarterly Report (10-q)

0001468639 false Q1 --12-31 http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember

Annual Report (10-k)

0001468639 false FY

Notification That Annual Report Will Be Submitted Late (nt 10-k)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549    ...

Current Report Filing (8-k)

0001468639 false 0001468639 2023-01-01 2023-01-01 iso4217:USD xbrli:shares...

Information Statement - All Other (definitive) (def 14c)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14C (R...